Vous êtes sur la page 1sur 1

G

B
F DRUG MECHANISM OF INDICATION CONTRAINDICATIONS ADVERSE EFFECTS NURSING

e
ACTION MANAGEMENT

ro
Generic name: Suppressesgastric Short termtreatment  hypersensitivity  stomach pain Assess
Omeprazole secretionby of active  pregnancy  nausea othermedications
inhibitinghydrogen/ duodenalulcer,gastro  lactation patientmaybe taking
Brand name: potassium esophageal reflux  vomiting foreffectiveness

n
andchildren
Omepron ATPaseenzyme disease(GERD),  Combination  diarrhea andinteraction.
systemin the includingerosive therapy with  headache

a
Classification: gastricparietal esophagitis and clarithromic in Monitor

re
Proton pump cell:characterize symptomaticGERD. should not be therapeuticeffectivenes
inhibitor asa gastric Long term treatment used in patients s andadverse reaction
acidpump of pathologic with hepatic atthe beginning
Dosage: inhibitor,since it hypersecretory impairment of therapy
40mg/10mL blockthe final step condition: to andperiodicallythrough

rn
of acid production maintain healing of out thetherapy.

m
erosive esophagitis.
Short term treatment Assess GI
of active benign system:bowel sounds
gastric ulcer 8 hrly,abdomen for
painand

id
swelling,appetite loss.

:c Monitor
hepaticenzymes.

Assessknowledge/teac
happropriate use of this

C
medication,intervention
s toreduce side
effects,and other
symptomsto report

N
a
N

Vous aimerez peut-être aussi